Kevin Oeffinger on the Importance of Cancer Survivorship in the Primary Care Setting
Kevin Oeffinger, MD, Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center, discusses the importance of cancer survivorship in the primary care setting.
Kevin Oeffinger, MD, Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center, discusses the importance of cancer survivorship in the primary care setting.
Oeffinger says cancer survivorship started to become
recognized as an important phase in a patient’s life about 10 years ago.
In 2003, the Institute of Medicine (IOM) issued a report on improving care and quality of life for childhood cancer survivors. Another report from 2005 found that primary care physicians were often unfamiliar with the consequences of cancer and rarely received guidance from oncologists. Patients reported feeling lost when transitioning back to their primary care physician after treatment.
Oeffinger says that as the number of cancer survivors has grown, it is now common for most primary care physicians to have cancer survivors in their practice.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
